Fas ligation in the presence of cycloheximide induced Jun N-terminal kinase 1 (JNK1) and JNK2 phosphorylation, caspase activation and cell death in the IL-3-dependent cell line BAF3. Fas-mediated apoptosis was prevented by expression of dominant negative FADD but not inhibited by IL-3. To investigate the role of JNK activation in this process, we examined cells overexpressing a JNK-speci®c phosphatase M3/6. M3/6 prevented Fas stimulation of JNK, but did not aect Fas-mediated caspase activation or cell death, demonstrating that JNK activation is not required for these processes.
Introduction
Fas is a member of the tumour necrosis receptor (TNFR) superfamily, which stimulates apoptosis when activated by Fas ligand (FasL), or cross-linked by agonistic antibodies (Nagata, 1997) . Fas-induced apoptosis is critical for the deletion of autoreactive T lymphocytes, for cytotoxic T lymphocyte cytolysis and for lymphocyte elimination in sites of immune privilege (Nagata, 1997) . Fas and TNFR1 share a region of homology in the cytoplasmic tail, the death domain, which is critical for signalling apoptosis (Itoh et al., 1991; Tartaglia et al., 1993) . The death domain recruits FADD upon Fas activation (Kischkel et al., 1995) , this then recruits and activates caspase 8 (Muzio et al., 1996; Boldin et al., 1996) . Other caspases, including 1 and 3, are subsequently activated (Enari et al., 1996) and caspase activation is necessary for Fas-mediated apoptosis (Tewari and Dixit, 1995) .
Fas stimulation also activates the JNK pathway (Latinis and Koretzky, 1996; Goillot et al., 1997; Lenczowski et al., 1997) . This may be due to a typical activation pathway involving Ras and Rac (Brenner et al., 1997) . It has also been proposed that JNK activation is downstream of caspase activation (Cahill et al., 1996; Roulston et al., 1998) . In this case it may follow cleavage and activation of p21-activated kinase (PAK) by caspases (Rudel et al., 1998) . JNK activation follows recruitment of Daxx, rather than FADD, to the Fas death domain (Yang et al., 1997; Chang et al., 1998 ) and a dominant negative form of FADD does not block JNK activation by Fas stimulation (Wajant et al., 1998) . JNK activation has also been demonstrated during apoptosis in response to irradiation, heat shock, cisplatin, NGF removal, and TNF or ceramide treatment (Chen et al., 1996; Zanke et al., 1996; Xia et al., 1995; Verheij et al., 1996; Cuvillier et al., 1996; Ichijo et al., 1997; Shirakabe et al., 1997) .
The role of JNK activation in apoptosis remains controversial. The use of over-expressed dominant negative alleles to block the JNK signalling pathway (Verheij et al., 1996; Xia et al., 1995; Goillot et al., 1997) may lead to unpredicted non-speci®c eects. We have previously utilized M3/6, a dual speci®city phosphatase which selectively inactivates JNK with little eect on p38 and ERK2 (Smith et al., 1997) . We demonstrated that expression of M3/6 in IL-3-dependent BAF3 cells speci®cally inhibits JNK activation, as measured by c-Jun kinase activity, but does not aect the induction of apoptosis by IL-3 removal or ceramide treatment (Smith et al., 1997) . The aim of the present study was to examine the eect of M3/6 over-expression on Fas-mediated apoptosis. We report that M3/6 inhibits Fas stimulation of JNK1 and JNK2 phosphorylation, but does not prevent Fas activation of caspases or cell death.
Results and discussion
Fas cross-linking induces JNK1/2 phosphorylation, caspase activation and cell death Fas signalling has been reported to activate JNK (Latinis and Koretzky, 1996; Goillot et al., 1997; Lenczowski et al., 1997) . To determine whether the Fas signalling pathway led to the activation of JNK in the IL-3 dependent cell line BAF3, we exposed these cells to the agonistic antibody Jo2 immobilized on tissue culture plates (Ogasawara et al., 1993) . Fas crosslinking in these cells increased JNK1 and JNK2 phosphorylation ( Figure 1a) . Inhibition of protein synthesis by cycloheximide also induced JNK1 and JNK2 phosphorylation, as previously described (Kyriakis et al., 1994) , and enhanced stimulation of JNK1 and JNK2 phosphorylation by Fas cross-linking ( Figure 1a ). IL-3 stimulation induced JNK1 and JNK2 phosphorylation, as we and others previously reported (Foltz and Scrader, 1997; Smith et al., 1997) , and did not aect JNK1 and JNK2 phosphorylation induced by Fas plus cycloheximide (Figure 1a) .
Stimulation of the caspase cascade is an early and essential event in Fas-triggered apoptosis (Tewari and Dixit, 1995) . We used a¯uorescent substrate for the sub-group of caspases 3, 7 and 10 to measure caspase activity following Fas triggering. Figure 1b (Itoh et al., 1991) to require cycloheximide to deliver an apoptotic signal. In the experiments of Figure 1 , 1% WEHI-3B conditioned medium was used as source of IL-3. This concentration is equivalent to 1 pM recombinant IL-3 in the stimulation of proliferation (data not shown). . A similar result was obtained with DNFADD clone 6, where 5.4% of cells died upon addition of Jo2 IL-3 concentrations up to 3.5 nM could not inhibit apoptosis induced by anti-Fas antibody (data not shown). These data show that Fas cross-linking stimulated JNK1 and JNK2 phosphorylation, caspase activation and cell death in BAF3 cells. Fas-mediated apoptosis was not inhibited by the presence of IL-3, which activates Akt (del Peso et al., 1997; Songyang et al., 1997) . This is distinct from c-Myc induced apoptosis in ®broblasts, which is Fas-mediated and blocked by IGF-1 induction of Akt (Hueber et al., 1997; Kauman-Zeh et al., 1997) .
FADD is recruited to the cytoplasmic tail of Fas upon triggering (Kischkel et al., 1995) . Over-expression of a truncated, dominant interfering form of FADD prevents Fas stimulation of apoptosis by blocking FADD recruitment . Figure 2a shows two stably transfected cell lines (DNFADD6 and DNFADD7) expressing a doublet of proteins at 23 kDa corresponding to the dominant interfering form of FADD. While these cells died upon IL-3 removal (data not shown), cell death upon Fas crosslinking was substantially inhibited (Figure 2b) . Thus, Fas stimulation of apoptosis in BAF3 cells required FADD recruitment.
JNK1/2 phosphorylation is not necessary for Fas-mediated killing
To determine the role of JNK activation in Fas stimulation of apoptosis, we have used the tyrosine/ threonine phosphatase M3/6 which selectively inactivates JNK Muda et al., 1996) . We have previously described BAF3-derived cell lines over-expressing M3/6 (Smith et al., 1997) . Figure  3a shows that there was reduced stimulation of JNK1 and JNK2 phosphorylation when M3/6-5 cells were exposed to anti-Fas antibody and essentially no JNK1 and JNK2 phosphorylation in M3/6-1 cells which Figure 3 JNK1/2 phosphorylation is not necessary for Fas-mediated killing (a) BAF3, M3/6 clone 1 and clone 5 cells, at 5610 5 cells/ml, with IL-3 and cycloheximide, were plated in control or Jo2 coated dishes for 4 h. 5610 5 cells per sample were then analysed for JNK1/2 expression and phosphorylation. Densitometry using Scion Image quantitated average level of JNK1/2 phosphorylation as BAF3: 1 (arbitrary value), BAF3+Jo2: 1.2, M3/6-1: unquanti®able, M3/6-5: 0.5, M3/6-5+Jo2, 0.6. (b) BAF3 and M3/6 clone 1 cells, at 5610 5 cells/ml, with cycloheximide as shown, were plated in control or Jo2 coated dishes for 4 h. Cells were then anlaysed for JNK activity using an in vitro kinase assay, with GSTc-jun as substrate. express a higher level of phosphatase (Smith et al., 1997) . Thus, M3/6 dephosphorylated both JNK1 and JNK2 isoforms. This was more accurately quantitated using by measuring JNK activity in vitro (Figure 3b ). Anti-Fas antibody stimulated a 2.2-fold increase in JNK activity in BAF3 cells. The level of JNK activity in M3/6-1 cells was considerably lower and anti-Fas antibody caused little stimulation. However, the M3/6 over-expressing cell lines showed similar caspase activation as the parental BAF3 cells in response to anti-Fas antibody (Figure 3c ) and the M3/6 overexpressing cells also died after Fas cross-linking (Figure 3d) . Thus, optimal stimulation of JNK1 and JNK2 phosphorylation was not required for Fas stimulation of apoptosis in BAF3 cells. Expression of a kinase-inactive JNK inhibited Fasmediated apoptosis in neuroblastoma cells (Goillot et al., 1997) and Fas-induced apoptosis was also prevented by forskolin which blocked JNK activation (Wilson et al., 1996) . However, expression of a dominant negative form of SEK1, an activator of JNK, had little eect on Fas-mediated apoptosis (Lenczowski et al., 1997) and thymocytes from sek1 7/7 mice were more susceptible to Fas-mediated cell death than wild type cells (Nishina et al., 1997) . In our study we have speci®cally inhibited JNK activation to show that JNK activity is not required for Fas-mediated apoptosis in BAF3 cells. JNK activation follows recruitment of Daxx, rather than FADD, to the Fas death domain (Yang et al., 1997; Chang et al., 1998; Wajant et al., 1998) . A dominant negative form of FADD blocks Fas mediated apoptosis in BAF3 cells, consistent with JNKindependent stimulation of apoptosis by Fas in these cells. A similar conclusion has been reached for TNFR1 signalling, where FADD recruitment leads to apoptosis, but does not activate JNK . However, JNK activation follows cellular stress or DNA damage which can lead to FasL induction Faris et al., 1998) , which may be a critical role of JNK in Fas-mediated apoptosis.
Materials and methods

Cell lines
BAF3 cells (Palacios and Steinmetz, 1985) and their derivatives were cultured in DMEM with 10% foetal bovine serum, 1% WEHI-3B conditioned medium as a source of IL-3 and 50 IU/ml Penicillin/Streptomycin, at 378C in 10% CO 2 . The M3/6-1 and M3/6-5 BAF3 cell clones expressing M3/6, a JNK phosphatase, were previously described (Smith et al., 1997) . The expression plasmid encoding a dominant interfering (DN) form of FADD was a gift from V Dixit, Genetech. This vector was co-electroporated with pBABEpuro (Morgenstern and Land, 1990) into BAF3 cells using a gene-pulser (Bio-Rad Laboratories), single cell clones were selected in 2 mg/ml puromycin by limiting dilution, and analysed for FADD expression by Western blot using anti-FADD mAb (Transduction Laboratories) at a dilution of 1 : 1000. Cell surface expression of Fas was assayed by¯ow cytometry using FACScan 1 . Cells were incubated either with anti-Fas mAb or hamster IgG antibody, followed by ā uorescin-isothiocyanate conjugated anti-hamster IgG (Pharmingen). BAF3 cells showed a peak channel shift of 2.3, DN ± FADD clone 7 of 2.1 and M3/6-1 of 6.5 with Jo2 compared to hamster IgG. Recombinant mouse IL-3 was purchased from R&D Systems.
Fas stimulation of JNK
Tissue culture dishes were coated with either puri®ed hamster anti-mouse Fas mAb clone Jo2 (Pharmingen) or puri®ed hamster IgG (Harlan) at 10 mg/ml in phosphate-buered saline (PBS) by incubation at 48C for 24 h. Wells were washed twice with DMEM prior to cell addition. Cells were washed three times with warm DMEM containing 10% FCS and antibiotics to deplete them of IL-3 and then brought to a density of 5610 5 cells/ml. Washed cells were cultured for 2 h, then treated with 1% WEHI-3B conditioned medium and/or 0.2 mg/ml cycloheximide (Sigma) as shown and seeded in coated wells. After 4 h, JNK activation was measured by washing cells with ice-cold PBS, lysing them in 26 Laemmli reducing sample buer, heating samples to 958C and separating proteins by SDS ± PAGE. Electroblotting and immunodetection was performed using the ECL system (Amersham) in accordance with the manufacturer's instructions. Anti-ACTIVE TM -JNK pAb (Promega) and anti-JNK (Santa Cruz) were used at dilutions of 1 : 2000 and 1 : 1500 respectively. JNK activity was also measured by in vitro phosphorylation of a GSTc-Jun fusion protein. At the end of the 4 h incubation in coated wells (as above) cells were collected, washed in ice-cold PBS and resuspended in ice-cold JNK lysis buer (20 mM HEPES pH 7.4, 2 mM EGTA, 1% Triton X-100, 10% glycerol, 1 mM DTT, 50 mM bglycerophosphate, 1 mM sodium orthovanadate, 10 mg/ml leupeptin, 1 mM PMSF, 2 mg/ml aprotinin). Extracts were precleared with protein A-agarose beads at 48C for 1 h. Then incubated with 2 ml of anti-JNK antibody (Santa Cruz) and 50 ml protein A beads at 48C for 3 h. The beads were washed three times with JNK lysis buer, three times with LiCl wash buer (500 mM LiCl, 100 mM Tris-Cl pH 7.6, 0.1% Triton X-100, 1 mM DTT) and three times with 25 mM HEPES pH 7.5, 0.2% Triton X-100, 1 mM EDTA. Then 30 ml of JNK assay buer (25 HEPES pH 7.5, 20 mM MgCl 2 , 20 mM b-glycerophosphate, 20 mM p-nitrophenyl phosphate, 0.1 mM sodium orthovanadate, 2 mM DTT) was added to 25 ml of beads together with 3 mg of GSTc-Jun, 5 mCi of [g-32 P]ATP (Amersham) and 20 mM ATP. The kinase mixtures were incubated at 308C for 20 min, then separated on a 10% SDS ± polyacrylamide gel. After electrophoresis, the gel was electroblotted onto a nitrocellulose membrane and autoradiographed. The relative amount of 32 P incorporated into GSTcJun in each sample was quantitated by liquid scintillation counting of the appropriate region of nitrocellulose membrane.
Cell viability and caspase activity following Fas aggregation
Cells were incubated for 20 h in coated wells under identical conditions to the JNK assay. The percentage of dead cells was determined by counting dead versus total cell numbers on a haemocytometer, using Trypan blue exclusion as a criterion of cell viability. Also, after 20 h incubation in coated wells, caspase activation was measured by washing cells with PBS and resuspending in ice-cold lysis buer (20 mM HEPES pH 8.0, 0.1% Triton X-100, 75 mM NaCl, 2.5 mM MgCl 2 , 0.1 mM EDTA, 10 mg/ml aprotinin, 10 mg/ ml leupeptin). The lysates were centrifuged for 15 min at 48C and the supernatant transferred to a new tube. An aliquot of each supernatant was taken for protein determination, by the method of Bradford. Then caspase activity was measured by adding to 2 ml of 10 mM DEVD ± AMC (Bachem) to 98 ml of cell lysate. Fluorescence was measured using a Fluoroskan Ascent FL (Labsystems)¯uorimeter (emission: 460 nm, excitation: 355 nm).
